How effective is obeticholic acid? How long does it take for patients to typically see results when it comes to treating liver disease?

Obeticholic acid is a drug used to treat liver diseases, mainly used to treat primary biliary cholangitis (PBC) and some other liver diseases. It helps slow down the accumulation of bile acids in the liver by acting on the liver's bile acid receptors, thereby reducing damage to liver cells. Its efficacy has been verified in multiple clinical studies, especially for PBC patients.

Obeticholic acid has shown significant efficacy in the treatment of primary biliary cholangitis (PBC). PBC is a chronic autoimmune liver disease that often leads to bile duct damage and liver failure. Obeticholic acid helps regulate the synthesis and secretion of bile acids by activating the farnesoid X receptor (FXR), reducing the accumulation of bile acids, thereby slowing down the process of liver damage. Clinical studies have shown that obeticholic acid can significantly improve liver function indicators in PBC patients, including reducing serum bile acid levels and improving liver-related biomarkers.

When using obeticholic acid to treat PBC, patients typically see results 3 to 6 months after starting treatment. At this time, the patient's liver function indicators, such as liver enzyme levels and serum bile acid levels, usually improve. When evaluating efficacy, doctors will regularly monitor the patient's liver function and evaluate the effectiveness of treatment through blood tests and imaging examinations. If the patient's condition is under control, maintenance therapy is usually continued until long-term efficacy is confirmed.
In addition to its use in treating PBC, obeticholic acid is also being studied for other types of liver disease, such as non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH). These diseases are also associated with bile acid accumulation and liver damage. Although obeticholic acid is currently approved mainly for the treatment of PBC, early studies have also shown its potential in the treatment of NAFLD and NASH. The effectiveness of obeticholic acid in these diseases is still under further study, but preliminary data suggests that obeticholic acid may help slow the progression of liver fibrosis and improve liver function.
Reference: https://en.wikipedia.org/wiki/Obeticholic_acid